Referenser Akne

1. Yang Z, Zhang Y, Mosler E, Hu J, Li H et al. Topical benzoyl peroxide for acne. Cochrane Database Syst Rev 2020 CD011154
2. Liu H, Yu H, Xia J, Liu L, Liu G et al. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. Cochrane Database Syst Rev 2020 CD011368
3. Cohen L, Seminario-Vidal L, Lockey RF. Dermatologic Problems Commonly Seen by the Allergist/Immunologist. J Allergy Clin Immunol Pract. 2020;8:102-12.
4. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012;379:361-372.
5. Behandling av akne - behandlingsrekommendation. Information från Läkemedelsverket, 2014; 4: 15-24
6. Hayran Y, Incel Uysal P, Öktem A, Aksoy G, Akdogan N, Yalcin B. Factors affecting adherence and patient satisfaction with treatment: a cross sectional study of 500 patients with acne vulgaris. J Dermatol Treat 2021;32:64-69.
7. Koo EB, Petersen TD, Kimball AB. Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris. J Am Acad Dermatol 2014;71:450-459.
8. Wilcock J, Kuznetsov L, Ravenscroft J, Rafiq MI, Healy E. New NICE guidance on acne vulgaris: implications for first-line management in primary care. Br J Gen Pract. 2021;71(713):568-70.
9. Kutlu Ö, Karadağ AS, Wollina U. Adult acne versus adolescent acne: a narrative review with a focus on epidemiology to treatment. An Bras Dermatol. 2023;98(1):75-83.
10. Fiedler F, Stangl GI, Fiedler E, Taube KM. Acne and Nutrition: A systematic review. Acta Derm Venereol 2017;97:7-9.
11. Blume-Peytavi U, Fowler J, Kemény L, Draelos Z, Cook-Bolden F, Dirschka T, et al. Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne. J Eur Acad Dermatol Venereol. 2020;34:166-73.
12. Tan J, Thiboutot D, Popp G, Gooderham M, Lynde C, Del Rosso J, et al. Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019;80:1691-9.
13. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-37.
14. Thiboutot D, Gollnick H, Bettoli V, Dreno B, Kang S, et al. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group. J Am Acad Dermatol 2009;60(Suppl):S1-50
15. Chernyshov PV, Tomas-Aragones L, Manolache L, Svensson A, Marron SE et al. Which acne treatment has the best influence on health-re-lated quality of life? Literature review by the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. J Eur Acad Dermatol Venereol 2018;32:1410-1419.
16. Samuels D, Rosenthal R, Lin R, Chaudhari S, Natsuaki M. Acne vulgaris and risk of depression and anxiety: A meta-analytic review. J Am Acad Dermatol 2020;83:532-41.
17. Claudel J, Auffret N, Leccia M, Poli F, Corvec S, Dréno B. Staphylococcus epidermidis: a potential new player in the physiopathology of acne? Dermatology 2019;235:287-294.
18. Niemeyer-van der Kolk T, van der Wall HEC, Balmforth C, Van Doorn MBA, Rissmann R. A systematic literature review of the human skin microbiome as biomarker for dermatological drug development. Br J Clin Pharmacol. 2018;84:2178-93